Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity

BACKGROUND: Stereotactic ablative radiotherapy (SABR) offers an alternative treatment for pancreatic cancer, with the potential for improved tumour control and reduced toxicity compared with conventional therapies. However, optimal dose planning and delivery strategies are unelucidated and gastro-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldsmith, Christy, Plowman, P. Nicholas, Green, Melanie M., Dale, Roger G., Price, Patricia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194644/
https://www.ncbi.nlm.nih.gov/pubmed/30340643
http://dx.doi.org/10.1186/s13014-018-1138-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194644/
https://www.ncbi.nlm.nih.gov/pubmed/30340643
http://dx.doi.org/10.1186/s13014-018-1138-3

Ejemplares similares